Dlbcl | search
Click here to view Dlbcl news from 60+ newspapers.
Bookmark or Share- Diffuse large B-cell lymphoma - WikipediaDiffuse large B-cell lymphoma (DLBCL) is a cancer of B cells, a type of lymphocyte that is responsible for producing antibodies. It is the most common form of non-Hodgkin lymphoma among adults, [1] with an annual incidence of 7–8 cases per 100,000 people per year in the US and UK.
- Treating B-Cell Non-Hodgkin Lymphoma - American Cancer SocietyDiffuse large B-cell lymphoma (DLBCL) tends to grow quickly. Most often, the treatment is chemotherapy (chemo), usually with 4 drugs known as CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), plus the monoclonal antibody rituximab (Rituxan).
- Diffuse Large B-Cell Lymphoma - Cleveland ClinicWhat is diffuse large B-cell lymphoma? Diffuse large B-cell lymphoma (DLBCL) is a fast-growing blood cancer and the most common form of non-Hodgkin lymphoma. There are different forms of DLBCL that happen when several different genetic changes, or mutations, turn healthy cells into cancerous cells.
- Diffuse Large B-Cell Lymphoma (DLBCL) - Macmillan Cancer SupportLearn about diffuse large b-cell lymphoma (DLBCL), a fast-growing type of non-Hodgkin lymphoma. Learn about symptoms, diagnosis, and treatment options.
- Diffuse Large B-Cell Lymphoma - Lymphoma Research FoundationDiffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL) in the United States and worldwide, accounting for about 22 percent of newly diagnosed cases of B-cell NHL in the United States. More than 18,000 people are diagnosed with DLBCL each year.
More
